Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Goff Brian Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 4 Goff Brian (CEO) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.
Txns: Sold 10,178 shares @ $25.48, valued at $259.3k
Exercised 22,691 restricted stock units @ $0
06/30/2023 4 Goff Brian (CEO) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.
Txns: Sold 11,449 shares @ $28.36, valued at $324.7k
Exercised 25,528 options to buy @ $0
08/09/2022 3/A Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
08/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/09/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
07/23/2021 4 Goff Brian (EVP & Chief Commercial Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.
Txns: Disposed/sold 150,832 shares @ $0
Disposed/sold 21,750 options to buy @ $100.14, valued at $2.2M
07/16/2021 4 Goff Brian (EVP & Chief Commercial Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.
Txns: Granted 30,643 shares @ $0
Granted 29,501 shares @ $0
06/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/18/2020 4 Goff Brian (EVP & Chief Commercial Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.
Txns: Granted 40,677 shares @ $0
Paid exercise price by delivering 18,134 shares @ $157.96, valued at $2.9M
Paid exercise price by delivering 3,261 shares @ $157.96, valued at $515.1k
06/09/2020 4 Goff Brian (EVP & Chief Commercial Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 1,642 shares @ $114.61, valued at $188.2k
03/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/11/2019 4 Goff Brian (EVP & Chief Commercial Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 1,643 shares @ $118.61, valued at $194.9k
03/05/2019 4 Goff Brian (EVP & Chief Commercial Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.
Txns: Granted 9,428 shares @ $0
03/04/2019 4 Goff Brian (EVP & Chief Commercial Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 670 shares @ $132.93, valued at $89.1k
02/11/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/12/2018 4 Goff Brian (EVP & Chief Commercial Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns: Sold 1,645 shares @ $118.53, valued at $195k
03/02/2018 4 Goff Brian (EVP & Chief Commercial Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns: Granted 8,940 shares @ $0
02/08/2018 4 Goff Brian (EVP & Chief Commercial Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns: Granted 15,894 shares @ $0
Sold 1,651 shares @ $116.31, valued at $192k
06/09/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
06/09/2017 3 Form 3 - Initial statement of beneficial ownership of securities
06/07/2016 4 Goff Brian (EVP and President, Hematology) has filed a Form 4 on Baxalta Inc
Txns: Granted 2,881 shares @ $0
Disposed/sold 70,047 shares @ $0
Disposed/sold 37,000 options to buy @ $23.15, valued at $856.6k
Disposed/sold 25,773 options to buy @ $32.42, valued at $835.6k
Disposed/sold 31,376 options to buy @ $31.86, valued at $999.6k
Disposed/sold 88,168 options to buy @ $32.04, valued at $2.8M
Disposed/sold 35,170 options to buy @ $31.5, valued at $1.1M
Disposed/sold 265,221 options to buy @ $31.5, valued at $8.4M
03/08/2016 4 Goff Brian (EVP and President, Hematology) has filed a Form 4 on Baxalta Inc
Txns: Paid exercise price by delivering 267 shares @ $39.74, valued at $10.6k
03/07/2016 4 Goff Brian (EVP and President, Hematology) has filed a Form 4 on Baxalta Inc
Txns: Granted 35,605 shares @ $0
Paid exercise price by delivering 1,338 shares @ $39.3, valued at $52.6k
Paid exercise price by delivering 303 shares @ $39.47, valued at $12k
02/17/2016 4 Goff Brian (EVP and President, Hematology) has filed a Form 4 on Baxalta Inc
Txns: Granted 552 shares @ $0
Paid exercise price by delivering 533 shares @ $39, valued at $20.8k
Granted 508 shares @ $0
08/13/2015 4 Form 4 - Statement of changes in beneficial ownership of securities
07/06/2015 4 Goff Brian (EVP and President, Hematology) has filed a Form 4 on Baxalta Inc
Txns: Acquired 4,154 shares @ $0
Acquired 28,154 shares @ $0
Acquired 37,000 options to buy @ $23.15, valued at $856.6k
Acquired 25,773 options to buy @ $32.42, valued at $835.6k
Acquired 31,376 options to buy @ $31.86, valued at $999.6k
Acquired 88,168 options to buy @ $32.04, valued at $2.8M
Granted 35,170 options to buy @ $31.5, valued at $1.1M
Granted 265,221 options to buy @ $31.5, valued at $8.4M
04/05/2012 3 Goff Brian (Director) has filed a Form 3 on IDENIX PHARMACEUTICALS INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy